{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/10237553"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "vate placement would, subject to the satisfaction of customary closing conditions, generate gross proceeds to GTXI of $21,272,455.42, or approximately $1.77625 per unit.GTXI is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, including treatments for prostate and breast cancer, cancer supportive care, includi" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "seekingalpha.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/451450518"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/10237553"] } } }
